Literature DB >> 27793537

Co-occurring Chronic Conditions and Economic Burden among Stroke Survivors in the United States: A Propensity Score-Matched Analysis.

Chanadda Chinthammit1, Bruce M Coull2, Mantiwee Nimworapan3, Sandipan Bhattacharjee4.   

Abstract

OBJECTIVE: This study examined the impact of co-occurring chronic conditions on healthcare expenditures among noninstitutionalized older adults (age ≥50 years) with stroke in comparison to non-stroke-matched controls.
METHODS: This study used a retrospective, cross-sectional, matched case-control design using pooled 2002-2012 Medical Expenditure Panel Survey (MEPS) data. Stroke survivors (N = 2913) were compared with matched controls (N = 8739) based on propensity scores. Healthcare expenditures for co-occurring chronic conditions were compared between stroke survivors and matched controls using ordinary least squares (OLS) regressions. All analyses were conducted in SAS 9.4 (SAS Institute Inc., Cary, NC, USA) using survey procedures adjusting for the complex survey design of the MEPS.
RESULTS: The annual mean total healthcare expenditures (expressed in 2012 United States dollars) were significantly higher among stroke survivors compared with matched non-stroke controls ($18,796 versus $14,391, P < .001). OLS regressions revealed that co-occurring chronic conditions partially explained the excess healthcare expenditures among stroke survivors. The annual mean total healthcare expenditures among stroke survivors were significantly higher for most of the co-occurring chronic conditions compared with matched controls (e.g., in presence of hyperlipidemia, stroke survivor expenditures were $18,807 compared to $15,807 among matched controls). Stroke survivors with co-occurring arthritis, diabetes, or hypertension had significantly greater inpatient, emergency room, and prescription expenditures compared with matched controls.
CONCLUSIONS: Stroke survivors experience a high economic burden. Interdisciplinary team-based treatment approaches to provide holistic care may help reduce the burden due to co-occurring chronic medical conditions among stroke survivors.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke; co-occurring chronic conditions; expenditures; healthcare; propensity score

Mesh:

Year:  2016        PMID: 27793537     DOI: 10.1016/j.jstrokecerebrovasdis.2016.09.040

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.

Authors:  Steve Ryder; Kathleen Fox; Pratik Rane; Nigel Armstrong; Ching-Yun Wei; Sohan Deshpande; Lisa Stirk; Yi Qian; Jos Kleijnen
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

2.  Cost-Effectiveness of Quantitative Magnetic Resonance Angiography Screening and Submaximal Angioplasty for Symptomatic Vertebrobasilar Disease.

Authors:  Darian R Esfahani; Dilip Pandey; Xinjian Du; Linda Rose-Finnell; Fady T Charbel; Colin P Derdeyn; Sepideh Amin-Hanjani
Journal:  Stroke       Date:  2018-08       Impact factor: 7.914

3.  Healthcare expenditures among community-dwelling adults with thyroid cancer in the United States: A propensity score matched analysis.

Authors:  Sandipan Bhattacharjee; Moteb Khobrani; Ziyad Alrabiah; Jawad Bilal; Irbaz Bin Riaz
Journal:  Heliyon       Date:  2019-06-24

4.  Will the zero-margin drug policy reduce the economic burden of stroke patients in China?

Authors:  Quan Fang; Degao Shang; Yunxia Zhang; Xinli Geng; Fang Liu; Qin Zhang; Xin Wang
Journal:  J Glob Health       Date:  2021-09-30       Impact factor: 4.413

5.  A Systematic Review of the Incidence, Prevalence, Costs, and Activity and Work Limitations of Amputation, Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis, Spinal Cord Injury, Stroke, and Traumatic Brain Injury in the United States: A 2019 Update.

Authors:  Jessica Lo; Leighton Chan; Spencer Flynn
Journal:  Arch Phys Med Rehabil       Date:  2020-04-24       Impact factor: 3.966

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.